Publications by authors named "Ping I Hsu"

Claim this Profile
R
Reply to Zhao et al.
Ping-I Hsu, Deng-Chyang Wu, Chih-An Shih, Yu-Hwa Liu

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and eradication of or gastric cancer prevention: Taipei Global Consensus II.
Jyh-Ming Liou, Peter Malfertheiner, Tzu-Chan Hong, Hsiu-Chi Cheng, Kentaro Sugano, Ping-I Hsu

Gut· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential changes of antibiotic resistances of in Taiwan from 2019 to 2024.
Pei-Jui Wu, Feng-Woei Tsay, Deng-Chyang Wu, Jyh-Chin Yang, Seng-Kee Chuah, Ping-I Hsu

World J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study.
Li-Fu Kuo, Wen-Chun Liu, Ming-Feng Li, Fu-Huan Huang, Chu-Kuang Chou, Ping-I Hsu

Oncology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future direction of Helicobacter pylori infection treatment.
Ping-I Hsu, Yoshio Yamaoka, Seng-Kee Chuah, Deng-Chyang Wu

Lancet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial.
Ping-I Hsu, Chien-Lin Chen, Chih-An Shih, Kuan-Yang Chen, Wei-Chen Tai

Am J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.
Sung-Shuo Kao, Deng-Chyan Wu, Seng-Kee Chuah, John Y Kao, Wei-Chen Tai, Ping-I Hsu

J Formos Med Assoc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Infection: A Systematic Review.
Chih-An Shih, Deng-Chyang Wu, Chang-Bih Shie, Ping-I Hsu

Microorganisms· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cut-off value of clarithromycin resistance in the treatment of infection: how low is low?
Ping-I Hsu, Seng-Kee Chuah, Yoshio Yamaoka, Deng-Chyang Wu

Gut· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Infection.
Chien-Lin Chen, I-Ting Wu, Deng-Chyang Wu, Wei-Yi Lei, Feng-Woei Tsay, Ping-I Hsu

Microorganisms· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the second-line treatment of infection: a narrative review.
Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai, Seng-Kee Chuah, Hsi-Chang Lee, Ping-I Hsu

Therap Adv Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ulceration caused by a persimmon bezoar.
Yoen Young Chuah, Yeong Yeh Lee, Ping-I Hsu

Br J Hosp Med (Lond)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of artificial intelligence in endoscopic image analysis for the diagnosis of a gastric cancer pathogen-Helicobacter pylori infection.
Chih-Hsueh Lin, Ping-I Hsu, Chin-Dar Tseng, Pei-Ju Chao, I-Ting Wu

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
Ping-I Hsu, Kuan-Yang Chen, Wei-Chen Tai, Jyh-Chin Yang, Feng-Woei Tsay

Am J Gastroenterol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REAP-HP survey 2020: Comparing the real-world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020.
Yoen-Young Chuah, Deng-Chyang Wu, Seng-Kee Chuah, Kuan-Yang Chen, Jyh-Chin Yang, Ping-I Hsu

Helicobacter· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the first-line treatment of infection in areas with high and low clarithromycin resistances.
Chih-An Shih, Chang-Bih Shie, Ping-I Hsu

Therap Adv Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection: A real-world clinical experience.
Jiunn-Wei Wang, Ping-I Hsu, Ming-Hong Lin, John Kao, Feng-Woei Tsay

J Gastroenterol Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors for esophagitis among human immunodeficiency virus-negative individuals.
Yan-Hua Chen, Tzu-Ming Jao, Yow-Ling Shiue, I-Jung Feng, Ping-I Hsu

World J Clin Cases· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial.
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Ping-I Hsu

J Formos Med Assoc· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users.
Jui-Ting Hsu, Ping-I Hsu, Chang-Bih Shie, Seng-Kee Chuah, I-Ting Wu, Jui-Che Hsu

Medicina (Kaunas)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.
Ping-I Hsu, Feng-Woei Tsay, John Y Kao, Nan-Jing Peng, Yan-Hua Chen

Helicobacter· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and prevention of hepatitis C virus reactivation during chemotherapy.
Yuan-Rung Li, Tsung-Hui Hu, Wen-Chi Chen, Ping-I Hsu, Hui-Chun Chen

World J Gastroenterol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
Zhi-Fu Tseng, Ping-I Hsu, Nan-Jing Peng, Sung-Shuo Kao, Feng-Woei Tsay

J Chin Med Assoc· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and eradication of for gastric cancer prevention: the Taipei global consensus.
Jyh-Ming Liou, Peter Malfertheiner, Yi-Chia Lee, Bor-Shyang Sheu, Kentaro Sugano, Ping-I Hsu

Gut· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of second-line regimens for eradication treatment: a systemic review and network meta-analysis.
Yen-Lin Chang, Yu-Chun Tung, Yu-Kang Tu, Hong-Zen Yeh, Jyh-Chin Yang, Ping-I Hsu

BMJ Open Gastroenterol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis